Diffuse cystic lung disease due to pulmonary metastasis of colorectal carcinoma  by Fielli, Mariano et al.
lable at ScienceDirect
Respiratory Medicine Case Reports 17 (2016) 83e85Contents lists avaiRespiratory Medicine Case Reports
journal homepage: www.elsevier .com/locate/rmcrCase reportDiffuse cystic lung disease due to pulmonary metastasis of colorectal
carcinoma
Mariano Fielli a, Fabio Avila a, Agustina Saino b, Deborah Seimah b,
Marcelo Fernandez Casares a, *
a Pulmonary Section, Department of Internal Medicine, Hospital Nacional Posadas, Buenos Aires, Argentina
b Pathology Department, Hospital Nacional Posadas, Buenos Aires, Argentinaa r t i c l e i n f o
Article history:
Received 22 November 2015
Received in revised form
22 December 2015
Accepted 23 December 2015
Keywords:
Cystic lung disease
Lung metastasis
Adenocarcinoma
Colorectal cancer* Corresponding author. Hospital Nacional Posadas,
Buenos Aires, 1684, Argentina.
E-mail addresses: mhﬁelli@gmail.com (M. Fiel
(F. Avila), agustinasaino@gmail.com (A. Saino), d
(D. Seimah), mfercasar@intramed.net.ar (M. Fernande
http://dx.doi.org/10.1016/j.rmcr.2015.12.006
2213-0071/© 2016 The Authors. Published by Elseviera b s t r a c t
The diffuse cystic lung diseases (DCLDs) are a pathophysiologically heterogeneous processes character-
ized by the presence of multiple thin-walled, air-ﬁlled spaces within the pulmonary parenchyma. The
most common causes of DCLD are lymphangioleiomyomatosis (LAM) and pulmonary Langerhans cell
histiocytosis (PLCH).
DCLD develops rarely as a result of malignancy, typically secondary to metastases from peripheral
sarcomas and mesenchymal tumors. DCLD have also been reported in a variety of other metastatic
disease such as adenocarcinoma.
Our case describes a patient with DCLD as a result of metastatic colorectal adenocarcinoma.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The diffuse cystic lung diseases (DCLD) are a group of entities
characterized by the presence of cysts in both lungs that are not
necessarily evenly distributed. The differential diagnosis is limited
and typically includes lymphangioleiomyomatosis (LAM) and pul-
monary Langerhans cell histiocytosis (PLCH) [1]. Rarely, metastatic
malignancy can present as DCLD. Metastatic leiomyoma, endome-
trial stromal sarcoma and cellular ﬁbrous histiocytic tumors have
been reported as causes of lung cysts [2,3].2. Case
A 49-year-old man was referred to our hospital with progres-
sively worsening shortness of breath, dry cough and weight loss of
approximately 10 kg. Three weeks prior to admission, the patient
had presented to another hospital and was treated with antibiotics
without improvement.
His past medical history was remarkable for tobacco addictionIllia and Marconi, El Palomar,
li), fabioaviladth@gmail.com
eborah_seimah@hotmail.com
z Casares).
Ltd. This is an open access article uand alcohol abuse. He also had used cocaine up to 2 years before
presentation. He did not report having any kind of environmental
exposures or pets.
On admission, his blood pressure was 140/80 mmHg. His tem-
perature was 38 C, and auscultation of his chest revealed dimin-
ished breath sounds and wheezing. The oxygen saturation (SpO2)
was 98% on room air.
Notable laboratory ﬁndings included the following: a white
blood cell count of 13,000/mL, a platelet count of 439,000/mL, and a
hemoglobin of 16.7 g/dL. HIV serology, antinuclear antibody (ANA)
and anti-neutrophil cytoplasmic antibody (ANCA) were negative.
The prostate-speciﬁc antigen (PSA) level was lower than 4.0 ng/mL.
Pulmonary function tests revealed a severe non-obstructive
defect, and a chest CT scan showed multiple lung cysts that pre-
dominated in the lower lobes (Fig. 1). A bronchoscopy was per-
formed, and no endoluminal or mucosal lesions were observed. A
bronchoalveolar lavage (BAL) culture was negative for bacterial
infection, Mycobacterium tuberculosis (and nontuberculous
mycobacteria) infection and fungal infection. The cytological ex-
amination did not ﬁnd atypia, and CD1a immunostaining of the BAL
cells was also negative.
The patient was treated with intravenous broad spectrum an-
tibiotics and steroids for 14 days, showing moderate improvement
of his respiratory symptoms. He was discharged from the hospital
and readmitted three weeks later with dyspnea and productivender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. High resolution CT showing multiple cysts, which markedly vary in size, in the
lower lobes and nodules that tend to cavitation.
Fig. 3. CK20: diffuse and strong positivity of tumor cells with CK20.
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He was alert, tachycardic and tachypneic. Chest auscultation
revealed diminished breath sounds and bilateral wheezing. The
SpO2 was 85% on room air.
Laboratory ﬁndings included the following: a white blood cell
count of 41,500/mL, a blood glucose of 331 mg/dL, and a C reactive
protein (CRP) level of 13.9 mg/dL.
A new chest CT scan demonstrated an increased number of cysts
(some of which were ﬁlled with mucus), bilateral ground glass
opacities and consolidation.
A diagnosis of nosocomial pneumonia was made. The patient
was started on antibiotic therapy with vancomycin and
piperacillin-tazobactam, but his clinical condition deteriorated
rapidly. He was intubated and mechanically ventilated. A second
bronchoscopy was performed, and transbronchial biopsies were
obtained.
The biopsy specimen revealed a small fragment of lungFig. 2. H & E: pulmonary parenchyma inﬁltrated by well-differentiated adenocarci-
noma with small foci of necrosis.parenchyma inﬁltrated by large cells, some of which had prominent
nucleoli and eosinophilic cytoplasm, showing gland formation
areas and focal necrosis. The tumor cells were CK-20-positive,
villin-positive, CK7-negative and TTF1-negative. The patient was
diagnosed with metastatic colorectal cancer.
The patient died on the 4th day after admission.3. Discussion
A lung cyst is deﬁned as an abnormal space that could be ﬁlled
with air or liquid. It has a thin wall that is covered by epithelium.
From a radiological point of view, a lung cyst is a rounded radio-
lucent or low attenuation formation of variable size with well-
deﬁned edges and a wall of less than 3 mm that separates it from
the normal lung parenchyma [4].
The differential diagnosis of patients with lung cysts is large
because many congenital or acquired diseases can be responsible
for their presence. An important distinction is whether they are
focal or multifocal or if they are scattered diffusely throughout both
lungs, which is termed “diffuse cystic lung disease” (DCLD). In thisFig. 4. Villin: cytoplasmic positivity of the tumor cells and brush border accent with
villin.
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LAM and PLCH [5]. Infrequently DCLD can develop as a result of
metastatic malignancies such as sarcomas, mesenchymal tumors or
lung adenocarcinoma [6e10].
It is important to distinguish a cyst from a cavity, which is an air
containing lesion with thickened and irregular walls due to central
necrosis. Cavities are relatively common in malignant lesions of the
lung [11].
Three mechanisms of cyst formation in metastatic lung disease
have been postulated as follows: central necrosis, inﬁltration by
malignant cells of preexisting bullae or small airway distension
through a valve effect caused by atypical cell inﬁltration [7,12].
The absence of a solid tumor often introduces difﬁculties in
histopathological diagnosis, requiring the aid of immunohisto-
chemical staining with monoclonal antibodies to tumor markers.
In our patient, lung adenocarcinoma was ﬁrst considered
because of his tobacco addiction and the presence of gland for-
mation areas in the histopathological examination of his lung tissue
(Fig. 2). The absence of cytokeratin 7 (CK 7) and thyroid tran-
scription factor 1 (TTF-1) immunostaining excluded lung cancer;
thus, a metastatic adenocarcinoma of unknown origin was
considered. A second panel of antibodies was positive for cytoker-
atin 20 (CK 20) (Fig. 3) and villin (Fig. 4), resulting in a diagnosis of
colorectal cancer [13,14].
The patient presented to the emergency department with
shortness of breath, weight loss and multiple lung cysts, which
turned out to be metastatic colorectal cancer. The absence of liver
metastases was noteworthy. The liver is usually the ﬁrst organ
affected by metastatic colon cancer. However, the blood coming
from the rectum returns to the heart through the vena cava,
bypassing the liver. Thus, rectal cancer patients have a much higher
incidence of pulmonary metastases than those with colon cancer
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